Loading clinical trials...
Loading clinical trials...
A Non-interventional Study Of The Safety Of Pneumococcal 13-valent Conjugate Vaccine (Prevenar 13) In The Philippines: A Post Marketing Surveillance Study
Prevenar 13 is safe for administration to Filipinos.
Filipino patients prescribed and administered with the vaccine will be monitored for safety Patients prescribed with the vaccine who provides consent for inclusion to the study will be observed.
Age
0 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Private Clinic
Lipa City, Batangas, Philippines
Private Clinic
Tagbilaran City, Bohol, Philippines
Private Clinic
Malolos, Bulacan, Philippines
Cebu Doctor University Hospital
Cebu, Cebu, Philippines
Room 220 The Doctor's Hospital, Inc.
Bacolod City, Negros Occidental, Philippines
Private Clinic
San Carlos City, Negros Occidental, Philippines
San Carlos Doctor's Hospital
San Carlos City, Negros Occidental, Philippines
Victorias Commercial Center
Victorias City, Negros Occidental, Philippines
Private Clinic
Dagupan, Pangasinan, Philippines
Private Clinic
Mangaldan, Pangasinan, Philippines
Start Date
December 1, 2011
Primary Completion Date
May 1, 2014
Completion Date
May 1, 2014
Last Updated
January 30, 2017
3,006
ACTUAL participants
Prevenar 13
BIOLOGICAL
Lead Sponsor
Pfizer
NCT06731374
NCT06044077
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06790290